Cargando…

mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics

An unheard mobilization of resources to find SARS-CoV-2 vaccines and therapies has been sparked by the COVID-19 pandemic. Two years ago, COVID-19’s launch propelled mRNA-based technologies into the public eye. Knowledge gained from mRNA technology used to combat COVID-19 is assisting in the creation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chavda, Vivek P., Soni, Shailvi, Vora, Lalitkumar K., Soni, Shruti, Khadela, Avinash, Ajabiya, Jinal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785933/ https://www.ncbi.nlm.nih.gov/pubmed/36560560 http://dx.doi.org/10.3390/vaccines10122150

Ejemplares similares

Anti-Androgenic Therapies Targeting the Luminal Androgen Receptor of a Typical Triple-Negative Breast Cancer
por: Khadela, Avinash, et al.
Publicado: (2022)

Phenytoin-induced dyskinesia: a case report
por: Shah, Kashvi C., et al.
Publicado: (2023)

Inhalable Vaccines: Can They Help Control Pandemics?
por: Chavda, Vivek P., et al.
Publicado: (2022)

Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes
por: Chavda, Vivek, et al.
Publicado: (2023)

Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review
por: Chavda, Vivek P., et al.
Publicado: (2022)

Advanced Phytochemical-Based Nanocarrier Systems for the Treatment of Breast Cancer
por: Chavda, Vivek P., et al.
Publicado: (2023)

Current status of Cancer Nanotheranostics: Emerging strategies for cancer management
por: Chavda, Vivek P, et al.
Publicado: (2023)

A global picture: therapeutic perspectives for COVID-19
por: Chavda, Vivek P, et al.
Publicado: (2022)

COVAX-19Ⓡ Vaccine: Completely blocks virus transmission to non-immune individuals
por: Chavda, Vivek P., et al.
Publicado: (2021)

Configuring Therapeutic Aspects of Immune Checkpoints in Lung Cancer
por: Khadela, Avinash, et al.
Publicado: (2023)

Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management
por: Chavda, Vivek P., et al.
Publicado: (2021)

Omicron Variant of SARS-CoV-2: An Indian Perspective of Vaccination and Management
por: Chavda, Vivek P., et al.
Publicado: (2023)

mRNA as a Therapeutics: Understanding mRNA Vaccines
por: Oğuz, Ferdi, et al.
Publicado: (2022)

mRNA-Based Vaccine for COVID-19: They Are New but Not Unknown!
por: Chavda, Vivek P., et al.
Publicado: (2023)

Contracting triple-negative breast cancer with immunotherapeutic armamentarium: recent advances and clinical prospects
por: Khadela, Avinash, et al.
Publicado: (2022)

The Delivery of mRNA Vaccines for Therapeutics
por: Nitika,, et al.
Publicado: (2022)

Epigenetics in Tuberculosis: Immunomodulation of Host Immune Response
por: Khadela, Avinash, et al.
Publicado: (2022)

mRNA vaccines: Past, present, future
por: Karam, Mia, et al.
Publicado: (2022)

Nanoparticle-Based Delivery Systems for Vaccines
por: Bezbaruah, Rajashri, et al.
Publicado: (2022)

Propolis and Their Active Constituents for Chronic Diseases
por: Chavda, Vivek P., et al.
Publicado: (2023)

mRNA therapeutics: New vaccination and beyond
por: Wei, Huan-Huan, et al.
Publicado: (2023)

HIV mRNA Vaccines—Progress and Future Paths
por: Mu, Zekun, et al.
Publicado: (2021)

Editorial: mRNA Vaccines and Future Epidemic, Pandemic, and Endemic Zoonotic Virus Infections
por: Parums, Dinah V.
Publicado: (2021)

Blood filtering system for COVID-19 management: novel modality of the cytokine storm therapeutics
por: Chavda, Vivek P., et al.
Publicado: (2023)

What does the success of mRNA vaccines tell us about the future of biological therapeutics?
por: Karikó, Katalin, et al.
Publicado: (2021)

mRNA vaccine-a desirable therapeutic strategy for surmounting COVID-19 pandemic
por: Chen, Peixian, et al.
Publicado: (2022)

Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world
por: Chavda, Vivek P., et al.
Publicado: (2022)

mRNA vaccine: a potential therapeutic strategy
por: Wang, Yang, et al.
Publicado: (2021)

Development of mRNA Vaccines/Therapeutics and Their Delivery System
por: Son, Sora, et al.
Publicado: (2023)

Future considerations for the mRNA-lipid nanoparticle vaccine platform
por: Igyártó, Botond Z, et al.
Publicado: (2021)

Prevalence and utility of pharmacokinetic data in preclinical studies of mRNA cancer vaccines
por: Roth, Gillie A., et al.
Publicado: (2023)

mRNA Vaccine Platform: mRNA Production and Delivery
por: Litvinova, V. R., et al.
Publicado: (2023)

mRNA vaccination in breast cancer: current progress and future direction
por: Jiang, Xiao-ting, et al.
Publicado: (2023)

Evolution and Progress of mRNA Vaccines in the Treatment of Melanoma: Future Prospects
por: Bafaloukos, Dimitrios, et al.
Publicado: (2023)

mRNA vaccine in cancer therapy: Current advance and future outlook
por: Li, Youhuai, et al.
Publicado: (2023)

2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update
por: Huang, Zoufang, et al.
Publicado: (2022)

Potential Anti-SARS-CoV-2 Prodrugs Activated by Phosphorylation and Their Role in the Aged Population
por: Chavda, Vivek P., et al.
Publicado: (2023)

Optimization of mRNA untranslated regions for improved expression of therapeutic mRNA
por: Asrani, Kirtika H., et al.
Publicado: (2018)

Dangers of mRNA vaccines
por: Ali, Tahoora, et al.
Publicado: (2021)

mRNA-Based Vaccines
por: Kowalzik, Frank, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_92jlduaovjsjo5n134le9hisjm